Perrigo (PRGO) Stock Overview
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
PRGO Community Fair Values
Create NarrativeSee what 11 others think this stock is worth. Follow their fair value or set your own to get alerts.
Perrigo Company plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$26.54 |
| 52 Week High | US$30.93 |
| 52 Week Low | US$23.14 |
| Beta | 0.45 |
| 1 Month Change | -0.86% |
| 3 Month Change | -4.19% |
| 1 Year Change | 1.10% |
| 3 Year Change | -35.30% |
| 5 Year Change | -52.00% |
| Change since IPO | 128.30% |
Recent News & Updates
Insufficient Growth At Perrigo Company plc (NYSE:PRGO) Hampers Share Price
Jun 25
Americas Awards And Supply Chain Savings Will Fuel Future Performance
Strategic investments in OTC brands and enhanced supply chain efficiencies are poised to improve Perrigo's operating margins and revenue growth.Recent updates
Insufficient Growth At Perrigo Company plc (NYSE:PRGO) Hampers Share Price
Jun 25Americas Awards And Supply Chain Savings Will Fuel Future Performance
Strategic investments in OTC brands and enhanced supply chain efficiencies are poised to improve Perrigo's operating margins and revenue growth.Is Perrigo (NYSE:PRGO) A Risky Investment?
Apr 28Perrigo: Opill Shows Where The Company Wants To Be
Apr 24Perrigo's (NYSE:PRGO) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 28Improved Revenues Required Before Perrigo Company plc (NYSE:PRGO) Shares Find Their Feet
Feb 06Perrigo Paves The Way For Recovery With Margin Focus
Jan 28Perrigo: A Consumer Health Company Close To An Inflection Point
Jan 20Is Perrigo (NYSE:PRGO) A Risky Investment?
Dec 06Perrigo Company: Great Combination Of Future Growth With A Low Valuation
Nov 19Perrigo (NYSE:PRGO) Has Announced A Dividend Of $0.276
Nov 07Improved Revenues Required Before Perrigo Company plc (NYSE:PRGO) Shares Find Their Feet
Oct 18Perrigo (NYSE:PRGO) Is Due To Pay A Dividend Of $0.276
Aug 21The Play On Perrigo
Aug 16Perrigo (NYSE:PRGO) Has Announced A Dividend Of $0.276
Aug 07Improved Revenues Required Before Perrigo Company plc (NYSE:PRGO) Shares Find Their Feet
Jul 03These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
May 29Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price
Mar 27These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
Feb 01The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet
Dec 28Perrigo's New Chapter: Its Bold Turnaround Plan Is Worth Buying
Nov 15The Prognosis For Perrigo
Aug 30Perrigo Outlook Healed By Repositioning
Jun 12Shareholder Returns
| PRGO | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0.3% | 0.5% | 3.4% |
| 1Y | 1.1% | -11.2% | 13.7% |
Return vs Industry: PRGO exceeded the US Pharmaceuticals industry which returned -11.2% over the past year.
Return vs Market: PRGO underperformed the US Market which returned 13.7% over the past year.
Price Volatility
| PRGO volatility | |
|---|---|
| PRGO Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 11.6% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 4.0% |
Stable Share Price: PRGO has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: PRGO's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1887 | 8,379 | Patrick Lockwood-Taylor | www.perrigo.com |
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Perrigo Company plc Fundamentals Summary
| PRGO fundamental statistics | |
|---|---|
| Market cap | US$3.65b |
| Earnings (TTM) | -US$164.70m |
| Revenue (TTM) | US$4.34b |
Is PRGO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRGO income statement (TTM) | |
|---|---|
| Revenue | US$4.34b |
| Cost of Revenue | US$2.76b |
| Gross Profit | US$1.58b |
| Other Expenses | US$1.74b |
| Earnings | -US$164.70m |
Last Reported Earnings
Mar 29, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.20 |
| Gross Margin | 36.38% |
| Net Profit Margin | -3.80% |
| Debt/Equity Ratio | 83.5% |
How did PRGO perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/30 13:50 |
| End of Day Share Price | 2025/06/27 00:00 |
| Earnings | 2025/03/29 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Perrigo Company plc is covered by 37 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Douglas Tsao | Barclays |